These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 16581075)
41. Gene intervention in ligament and tendon: current status, challenges, future directions. Hildebrand KA; Frank CB; Hart DA Gene Ther; 2004 Feb; 11(4):368-78. PubMed ID: 14724683 [TBL] [Abstract][Full Text] [Related]
42. Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor beta1 gene. Guo X; Zheng Q; Yang S; Shao Z; Yuan Q; Pan Z; Tang S; Liu K; Quan D Biomed Mater; 2006 Dec; 1(4):206-15. PubMed ID: 18458408 [TBL] [Abstract][Full Text] [Related]
43. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences. Chuah MK; Vandendriessche T Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006 [TBL] [Abstract][Full Text] [Related]
44. Technology insight: gene transfer and the design of novel treatments for rheumatoid arthritis. Moritz F; Distler O; Ospelt C; Gay RE; Gay S Nat Clin Pract Rheumatol; 2006 Mar; 2(3):153-62. PubMed ID: 16932675 [TBL] [Abstract][Full Text] [Related]
45. Translation of science to surgery: linking emerging concepts in biological cartilage repair to surgical intervention. Moran CJ; Shannon FJ; Barry FP; O'Byrne JM; O'Brien T; Curtin W J Bone Joint Surg Br; 2010 Sep; 92(9):1195-202. PubMed ID: 20798434 [TBL] [Abstract][Full Text] [Related]
46. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer. Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183 [TBL] [Abstract][Full Text] [Related]
48. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Morille M; Passirani C; Vonarbourg A; Clavreul A; Benoit JP Biomaterials; 2008; 29(24-25):3477-96. PubMed ID: 18499247 [TBL] [Abstract][Full Text] [Related]
49. Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences. Chuah M; Vandendriessche T Verh K Acad Geneeskd Belg; 2007; 69(5-6):315-34. PubMed ID: 18351211 [TBL] [Abstract][Full Text] [Related]
50. Young, adult, and old rats have similar changes in mRNA expression of many skeletal genes after fracture despite delayed healing with age. Meyer RA; Desai BR; Heiner DE; Fiechtl J; Porter S; Meyer MH J Orthop Res; 2006 Oct; 24(10):1933-44. PubMed ID: 16894589 [TBL] [Abstract][Full Text] [Related]
52. Potential of AAV vectors in the treatment of metabolic disease. Alexander IE; Cunningham SC; Logan GJ; Christodoulou J Gene Ther; 2008 Jun; 15(11):831-9. PubMed ID: 18401432 [TBL] [Abstract][Full Text] [Related]
53. Chapter 20: Gene therapy perspectives for nerve repair. Zacchigna S; Giacca M Int Rev Neurobiol; 2009; 87():381-92. PubMed ID: 19682649 [TBL] [Abstract][Full Text] [Related]
54. Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption. Lamoureux F; Richard P; Wittrant Y; Battaglia S; Pilet P; Trichet V; Blanchard F; Gouin F; Pitard B; Heymann D; Redini F Cancer Res; 2007 Aug; 67(15):7308-18. PubMed ID: 17671200 [TBL] [Abstract][Full Text] [Related]